Document is current
Any future updates will be listed below
-
Authors
Blume-Peytavi, Ulrike
Craiglow, Brittany
Netravali, Ilka Arun
Doche, Isabella
Harada, Kazutoshi
Wajsbrot, Dalia
Bonfanti, Gianluca
Ishowo-Adejumo, Rahmat
Wolk, Robert
Tran, Helen
- License Information
-
More Information
Article History
Received: 30 June 2026
Accepted: 24 August 2026
First Online: 1 October 2026
Declarations
Conflict of Interest: Ulrike Blume-Peytavi has received honoraria for lectures, advisory board, and/or clinical studies from AbbVie, Amryt, Bayer, Boots Healthcare, Cantabria Labs, Cassiopeia, CeraVe, Concert Pharmaceuticals/Sun Pharma, Dermocosmétique Vichy, Galderma Laboratorium GmbH, Eli Lilly, Laboratoires Bailleuil, Legacy Healthcare, LEO-Pharma, Novartis, Pfizer, Sanofi, and Regeneron. Brittany Craiglow has received honoraria and/or fees from AbbVie, BiologicsMD, Dermavant, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, and Sun Pharmaceuticals. Ilka Arun Netravali is involved in performing clinical trials and/or is a member of commercial and scientific advisory boards, consultant, and/or speaker for Arcutis Biotherapeutics, Inc., Eli Lilly and Company, Pfizer Inc, and Verrica Pharmaceuticals Inc. Isabella Doche has received honoraria and/or fees from Pfizer, Pierre Fabre-Ducray, Loreal, Theraskin, Ache, GSK, Cantabria Lab, and Panalab, and royalties from Jaypee Medical Publisher. Kazutoshi Harada has received lecture fees and/or advisory fees from Eli Lilly, Janssen Pharmaceuticals, Maruho, and Pfizer Inc, and research funding for clinical trials from Eli Lilly. Gianluca Bonfanti is an employee of Engineering Ingegneria Informatica, which is a paid subcontractor to Health Services Consulting Corporation. Dalia Wajsbrot, Rahmat Ishowo-Adejumo, Robert Wolk, and Helen Tran are employees of Pfizer Inc. and hold stock or stock options in Pfizer Inc.
Ethical Approval: This study was conducted in accordance with the protocol and with the consensus ethical principles derived from international guidelines, including the Declaration of Helsinki and CIOMS International Ethical Guidelines; applicable International Council for Harmonisation Good Clinical Practice guidelines; and applicable regional laws and regulations, including privacy laws. All participants or their legally authorized representative provided written informed consent. The protocols for the studies on which this analysis was based were reviewed and approved by the institutional review boards or ethics committees of the participating institutions.
